Skip to main content
星昊医药 logo

星昊医药 — Investor Relations & Filings

Ticker · 920017 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2023-11-22 Governance Information
Country CN China
Listing Beijing Stock Exchange 920017

About 星昊医药

https://www.sunho.com.cn/

Beijing Sunho Pharmaceutical Co., Ltd. is a technology-driven enterprise specializing in the research, development, manufacturing, and commercialization of advanced pharmaceutical preparations. The company focuses on high-barrier drug delivery systems, including sustained-release, controlled-release, and complex injection technologies. Its core business encompasses the production of a diverse portfolio of chemical drugs and biological products, alongside comprehensive Contract Development and Manufacturing Organization (CDMO) services. Sunho Pharmaceutical operates modern, GMP-compliant production facilities designed to support the entire lifecycle of drug development, from pilot-scale testing to large-scale commercial manufacturing. By leveraging its proprietary formulation platforms, the company provides integrated solutions for complex dosage forms, catering to both domestic and international pharmaceutical markets.

Recent filings

Filing Released Lang Actions
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled as the "Board Secretary Work Rules" of Beijing Xinghao Pharmaceutical Co., Ltd. It details the qualifications, duties, appointment, and removal procedures of the company's board secretary. It includes procedural and governance-related content, such as responsibilities, qualifications, and reporting obligations of the board secretary. There is no financial data, earnings information, or report publication announcement. The document is a governance-related internal regulation rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length is 3752 characters, which is not extremely short, and it is a full text of the governance rules, not an announcement or certification. Hence, the classification is CGR with high confidence.
2023-11-22 Chinese
承诺管理制度
Governance Information Classification · 95% confidence The document is titled '北京星昊医药股份有限公司承诺管理制度' which translates to 'Beijing Xinghao Pharmaceutical Co., Ltd. Commitment Management System'. It details the company's internal commitment management policies, including the responsibilities of controlling shareholders, actual controllers, related parties, and the company itself. It references legal and regulatory frameworks such as the Company Law, Securities Law, and listing rules. The document includes the approval process by the board of directors and mentions submission to the shareholders' meeting. It is a governance-related document outlining internal rules and procedures rather than a financial report, announcement of voting results, or other categories. The document length is 2334 characters, which is relatively short but contains substantive policy content. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-11-22 Chinese
董事会审计委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the "Board Audit Committee Working Rules" of Beijing Xinghao Pharmaceutical Co., Ltd. It details the structure, responsibilities, procedures, and rules of the company's audit committee. It is a governance-related document outlining internal board committee rules rather than financial results, audit reports, or announcements. The document is not an announcement of a report but the actual governance policy text. It does not contain financial statements or audit opinions, so it is not an Annual Report (10-K), Audit Report (AR), or Interim Report (IR). It is not a regulatory filing or announcement but a governance information document describing board committee rules and governance structure. Therefore, the best fitting category is Governance Information (CGR). The document length is 3543 characters, which is sufficient for a detailed governance document but not a full financial report. Confidence is high given the clear content and purpose.
2023-11-22 Chinese
董事会战略委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Board of Directors Strategic Committee Working Rules' of Beijing Xinghao Pharmaceutical Co., Ltd. It details the composition, responsibilities, decision-making procedures, and meeting rules of the Board's Strategic Committee. There is no financial data, no report of financial results, no announcement of voting results, no mention of shareholder meetings, no earnings data, no audit information, and no regulatory filings or certifications. The document is a governance-related internal rules document describing the structure and function of a board committee. Therefore, it fits best under the category of Governance Information (CGR). The document length is 2863 characters, which is consistent with a detailed governance document rather than a brief announcement or report publication notice.
2023-11-22 Chinese
独立董事辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of an independent director from the company's board. It details the resignation date, reasons, and the impact on the board's composition and operations. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the resignation notice. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-11-16 Chinese
第六届董事会第十八次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 18th meeting of the 6th Board of Directors of Beijing Xinghao Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and compliance with legal requirements. The content focuses on board decisions such as approval of subsidiary land purchase and signing of a fundraising supervision agreement. There is no financial data, earnings information, or detailed report content. The document is clearly a Board/Management Information announcement about board meeting resolutions and decisions, not a full report or financial statement. The document length is short (1241 characters), consistent with a meeting resolution announcement rather than a full report.
2023-11-09 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.